CFM
PBH icon

Catalyst Funds Management’s Prestige Consumer Healthcare PBH Stock Holding History

Catalyst Funds Management’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-900
Closed -$64.9K – 990
2024
Q3 		$64.9K Buy
+900
New +$63.7K 0.01% 673
2024
Q2 		– Sell
-100
Closed -$7.26K – 1489
2024
Q1 		$7.26K Buy
+100
New +$6.69K ﹤0.01% 936

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Catalyst Funds Management's PBH Position: Q4 2024 in Review

Catalyst Funds Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2024, closing a stake of 900 shares — an estimated $64.9K sold.

Catalyst Funds Management first reported a position in PBH in Q1 2024 and held it in 2 quarters. The position peaked at $64.9K in Q3 2024. 336 funds tracked by Wall St. Rank hold PBH as of Q4 2024.

  • Catalyst Funds Management reported no remaining Prestige Consumer Healthcare position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 900 Prestige Consumer Healthcare shares in Q4 2024, an estimated $64.9K.
  • Catalyst Funds Management first reported a position in Prestige Consumer Healthcare in Q1 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Prestige Consumer Healthcare position peaked at $64.9K in Q3 2024.
  • 336 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.